Regulatory & Legal

The SFC-licensed platform now offers the most compliant tokenized securities in Hong Kong, bridging institutional capital with on-chain finance.

From Taiwan to the world, Gogoro's battery swapping network is reshaping urban transport. Can its proven model solve Asia's mobility and pollution woes?

The pharma firm hit pause on a crucial reverse stock split needed to keep its Nasdaq listing, citing "timing considerations" and raising investor questions.

Keurig Dr Pepper's upcoming Q1 results are more than just numbers; they're the first look at a company on the brink of a massive transformation.

At a key investor conference, Renibus is pitching its two Phase 3 drugs, including one with a strategic pivot after a challenging trial result.

An inmate's escape by allegedly impersonating another has triggered a national investigation, exposing critical flaws in Canada's correctional system.

Cambridge's acquisition of an $800M firm highlights a growing industry trend of broker-dealers becoming buyers to solve the advisor succession crisis.

A Texas clinic is combining brain health therapy, facial rejuvenation, and body sculpting in a novel, 'whole person' approach to wellness and recovery.

A new legal report reveals cyberattacks are more expensive and litigious than ever, with AI and supply chain weaknesses creating unprecedented new pressures.

As GLP-1 drug demand soars, Nordic Cold Chain Solutions launches a new lab to solve the complex puzzle of keeping these sensitive medicines safe.

An award-winning AI now verifies hospital meals, promising to reduce errors and improve patient safety one tray at a time. Here’s how it works.

A Florida firm says its 15-year study proves 'Hypergrowth Stocks' are a unique asset class. But can a 40% growth metric truly redefine investing?

A new report reveals a stark divide in U.S. child care funding. A family's access to care—and their economic future—increasingly depends on their state.

The World Series of Poker is back on ESPN with a new format and producer Peyton Manning. Can this high-stakes partnership recapture the magic of the 2000s?

An ambitious plan to democratize wealth for small businesses, backed by prominent investors, confronts significant SEC hurdles and legislative dependencies.

A groundbreaking study of 78,000 people shows most with acne and psoriasis manage their conditions alone, outside the clinic. Here's what it means.

As OpenAI shelves its costly Sora video project, smaller firms like ReelTime tout a new path: efficiency over brute force. Is this the future of AI video?

AI-powered deepfakes bypass tech defenses to exploit human trust, costing firms millions. New research reveals how to fight this emerging cyber threat.

Over 500 rural homes and businesses gain high-speed internet access as a public-private partnership bridges the digital divide in Western North Carolina.

A US firm is bringing embryo screening for chronic diseases to major IVF networks, sparking debate on the future of family planning and genetic health.